Dinarvand R - Search Results

1

Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors.

Bastani P, Dinarvand R, SamadBeik M, Pourmohammadi K. Bastani P, et al. Among authors: dinarvand r. J Res Pharm Pract. 2016 Jan-Mar;5(1):35-42. doi: 10.4103/2279-042X.176553. J Res Pharm Pract. 2016. PMID: 26985434 Free PMC article.

2

Resource allocation and purchasing arrangements to improve accessibility of medicines: Evidence from Iran.

Bastani P, Mehralian G, Dinarvand R. Bastani P, et al. Among authors: dinarvand r. J Res Pharm Pract. 2015 Jan-Mar;4(1):9-17. doi: 10.4103/2279-042X.150045. J Res Pharm Pract. 2015. PMID: 25710045 Free PMC article.

3

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study.

Hashemi Meshkini A, Kebriaeezadeh A, Dinarvand R, Nikfar S, Habibzadeh M, Vazirian I. Hashemi Meshkini A, et al. Among authors: dinarvand r. Daru. 2012 Aug 30;20(1):19. doi: 10.1186/2008-2231-20-19. Daru. 2012. PMID: 23351841 Free PMC article.

4

Impact of Corporate Reputation on Brand Differentiation: An Empirical Study from Iranian Pharmaceutical Companies.

Vahabzadeh A, Vatanpour H, Dinarvand R, Rajabzadeh A, Salamzadeh J, Mohammadzadeh M. Vahabzadeh A, et al. Among authors: dinarvand r. Iran J Pharm Res. 2017 Fall;16(4):1658-1670. Iran J Pharm Res. 2017. PMID: 29552075 Free PMC article.

5

National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.

Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, Sayyari AA, Asadi-Lari M, Delavari A, Farzadfar F, Haghdoost A, Heshmat R, Jamshidi H, Kalantari N, Koosha A, Takian A, Larijani B. Peykari N, et al. Among authors: dinarvand r. J Diabetes Metab Disord. 2017 Jan 23;16:3. doi: 10.1186/s40200-017-0288-4. eCollection 2017. J Diabetes Metab Disord. 2017. PMID: 28127543 Free PMC article. Review.

6

Assessing the Effectiveness AND Cost-Effectiveness of Audit and Feedback on Physician's Prescribing Indicators.

Soleymani F, Rashidian A, Dinarvand R, Kebriaeezade A, Hosseini M, Abdollahi M. Soleymani F, et al. Among authors: dinarvand r. Value Health. 2014 Nov;17(7):A797. doi: 10.1016/j.jval.2014.08.473. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202993 Free article. No abstract available.

7

A model for developing a decision support system to simulate national drug policy indicators.

Abdollahiasl A, Nikfar S, Kebriaeezadeh A, Dinarvand R, Abdollahi M. Abdollahiasl A, et al. Among authors: dinarvand r. Arch Med Sci. 2011 Oct;7(5):744-6. doi: 10.5114/aoms.2011.25546. Epub 2011 Nov 8. Arch Med Sci. 2011. PMID: 22291816 Free PMC article. No abstract available.

8

Preparation and comparison of chitosan nanoparticles with different degrees of glutathione thiolation.

Yousefpour P, Atyabi F, Dinarvand R, Vasheghani-Farahani E. Yousefpour P, et al. Among authors: dinarvand r. Daru. 2011;19(5):367-75. Daru. 2011. PMID: 22615683 Free PMC article.

9

Stealth Nanogels of Histinylated Poly Ethyleneimine for Sustained Delivery of Methotrexate in Collagen-Induced Arthritis Model.

Abolmaali S, Tamaddon A, Kamali-Sarvestani E, Ashraf M, Dinarvand R. Abolmaali S, et al. Among authors: dinarvand r. Pharm Res. 2015 Oct;32(10):3309-23. doi: 10.1007/s11095-015-1708-0. Epub 2015 May 12. Pharm Res. 2015. PMID: 25964048

10

PEGylation of Octreotide Using an α,β-unsaturated-β'-mono-sulfone Functionalized PEG Reagent.

Erfani-Jabarian L, Dinarvand R, Rouini MR, Atyabi F, Amini M, Mohammadhosseini N, Shafiee A, Foroumadi A. Erfani-Jabarian L, et al. Among authors: dinarvand r. Iran J Pharm Res. 2012 Summer;11(3):747-53. Iran J Pharm Res. 2012. PMID: 24250501 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page